The Estimated TARE Procedure Cost in India starts from USD 10000 TO USD 25000. The costs involved are determined by a variety of factors, including:
Transarterial Radioembolization (TARE) stands as an inventive therapeutic approach, seamlessly merging radiation therapy with embolization techniques to address liver tumors. Employing a minimally invasive methodology, TARE entails the introduction of Yttrium-90-laden microspheres into the blood vessels that intricately supply and nurture the burgeoning tumor.
The Transarterial Radioembolization (TARE) Procedure in India represents a pivotal treatment modality aimed at individuals grappling with liver cancer, scientifically termed Hepato Cellular Carcinoma (HCC). This avant-garde approach encompasses a minimally invasive treatment procedure executed through a transcatheter intra-arterial intervention, overseen by India’s preeminent Interventional Radiologist.
Comparatively evaluated against its counterparts in developed nations, the Cost of Transarterial Radioembolization Procedure in India emerges as notably economical. The comprehensive cost structure of this therapeutic regimen varies contingent upon the radiologist’s expertise and the specific nature and gravity of the tumor.
Transcatheter Intra-arterial Radioembolization (TARE) represents a procedural innovation harnessed by interventional radiologists to address both primary and secondary liver cancers. The TARE procedure involves the precise delivery of radioactive material directly into the liver tumor through the hepatic artery, achieved by a catheter placement in a peripheral artery. The introduced radioactive substance becomes concentrated within the tumor tissue, emitting targeted radiation that culminates in the demise of tumor cells.
Notably, the radioactivity contained within the infused beads administers potent radiation doses to malignant cells while sparing healthy tissues. This therapeutic approach holds particular significance for patients afflicted with multiple or inoperable liver tumors. It is essential, however, to underscore that TARE Therapy in India assumes a palliative role: while it extends and enhances the patient’s life, it does not effect a cure.
This specific procedure is termed Transarterial Radioembolization with yttrium-90 (TARE-Y90). The TARE Procedure in India finds utility in the subsequent scenarios:
TARE Procedure (Therapy) in India is only a palliative treatment. It may help to prolong the patient’s life and enhance overall quality of life, but it cannot cure the liver tumor. An oncologist may recommend TARE therapy in the following situations:
In particular circumstances, the patient may be advised against receiving treatment. These includes:
Radioembolization goes through a blood vessel and right to the liver tumor. The radioactive material doesn’t pass through healthy parts of the body to reach the cancer cells, as happens in other kinds of radiation treatments.
Sometimes doctors use radioembolization with other treatments, like chemotherapy and surgery.
The interventional radiologist will explain the risks and likely benefits of radioembolization. If you decide the procedure is right for your child, you’ll be asked to sign a consent (permission) form. Then, you will schedule the procedure.
Before the procedure, the care team will let you know:
Before the mapping operation begins, the patient will provide their informed consent, which includes detailed information about the TARE treatment.
An Interventional Radiologist in India will conduct a hepatic angiography to visualize the arterial structure within the liver and carefully coil the arteries connected to healthy organs and tissues.
In the course of Hepatic Angiography in India, a catheter will be introduced through a minor puncture in the patient’s groin. Additionally, the interventional radiologist will administer Tc99m AA, aiding in replicating the precise distribution pattern of TARE particles within the liver.
Subsequently, the patient will be discharged from the hospital and scheduled for a follow-up appointment after approximately one week.
During this interim, the interventional radiologist and nuclear medicine specialist will analyze the scans and imaging outcomes to ascertain the appropriate dosage of Y-90 to be administered inside the patient’s body.
For the subsequent stage of the procedure, the radiologist will employ the same catheter, inserting it into the hepatic artery. TARE particles, consisting of glass or resin beads infused with Yttrium-90—a radioactive substance with a gradual cancer cell-targeting effect—will then be introduced into the hepatic artery that leads to the tumors.
The duration of this treatment typically spans 3 to 4 hours, contingent upon the tumor’s location and severity.
The patient will be hospitalized for 4-5 days following the procedure. This is important because the patient must be placed in radioactive isolation to protect others from unwanted radiation exposure.
Transarterial Radioembolization Procedure in India allows patients with complex or inoperable liver tumors to live for many months to several years longer. It also sets the path for an improved way of living.
In comparison to other radiation therapies, radioembolization has fewer severe side effects.
TARE doesn’t require any surgical incisions. A surgeon may make a small incision around the groin to place a catheter.
Radioembolization produces more radiation than any other external beam therapy.
Problems are not common, however they do occur on occasion. They may include the following: